SCOTUS Oral Arguments

The Life of the Law

Supreme Court oral argument audio recordings paired with show notes that include helpful information and links to additional resources on the Supreme Court's website. Independent feed. NOT affiliated with the Supreme Court of the United States or any other entity. Audio credit to the Supreme Court of the United States. Image credit to Ian Hutchinson, https://unsplash.com/photos/U8WfiRpsQ7Y.

About PodLP

PodLP is the leading podcast app for feature phones. With 10M+ installs in nearly every country, PodLP is available for KaiOS on the KaiStore and JioStore, as well as Cloud Phone and Android. If you're interested in promoting "SCOTUS Oral Arguments" on PodLP, contact sales@podlp.com.

Screenshots are mockup renders of PodLP for KaiOS. Actual design may vary based on platform, operating system, and app version.

SCOTUS Oral Arguments

Episodes (181)

Apr 29th Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.
Apr 29th Mullin, Sec. of Homeland Security v. Doe
Apr 28th Cisco Systems v. Doe I

SCOTUS Oral Arguments

Apr 29, 2026
1¼ hours
28 MB

Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., No. 24-889 Argued on Apr 29 2026. For petitioners: Charles B. Klein, Washington, D. C.; and Malcolm L. Stewart, Deputy Solicitor General, Department of Justice, Washington, D. C. (for United States, as amicus curiae.) For respondents: Michael R. Huston, Phoenix, Ariz. Question Presented: Congress passed the Hatch-Waxman Act "[t]o facilitate the approval of generic drugs as soon as patents allow." Caraco Pharm. Labs., Ltd. v. Novo Nordisk A/S , 566 U.S. 399, 405 (2012). Recognizing that many drugs are...

SCOTUS Oral Arguments

Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.

The Life of the Law

00:00 -01:00:20